4.6 Review

The IL-33/ST2 axis: Role in health and disease

Journal

CYTOKINE & GROWTH FACTOR REVIEWS
Volume 26, Issue 6, Pages 615-623

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2015.07.017

Keywords

IL-33; ST2; Autoimmunity; Inflammatory bowel diseases; Table of contents

Funding

  1. [CONICYT130037]
  2. [FONDECYT1120577]
  3. [FONDECYT3150328]

Ask authors/readers for more resources

IL-33, an IL-1 family member, is expressed by many cell types and can regulate gene transcription. IL-33 is released upon cell necrosis and the precursor form is enzymatically processed, and then drives inflammation as a damage-associated molecular pattern. The IL-33 receptor ST2, encoded by IL1RL1, is expressed as both a membrane-anchored receptor (ST2L) activated by IL-33, and as a soluble variant (sST2) that exhibits anti-inflammatory properties. The IL-33/ST2 axis is involved in the pathogenesis of atopic and autoimmune diseases, cancer, and central nervous system disorders. Here, we review recent findings on the role of the IL-33/ST2 axis in health and disease. (C) 2015 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available